Research Priorities for Atrial Fibrillation in Australia: A Statement From the Australian Cardiovascular Alliance Clinical Arrhythmia Theme

IF 2.2 4区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Heart, Lung and Circulation Pub Date : 2024-11-01 DOI:10.1016/j.hlc.2024.08.008

Adrian D. Elliott , Melissa E. Middeldorp , Julie R. McMullen , Diane Fatkin , Liza Thomas , Kylie Gwynne , Adam P. Hill , Catherine Shang , Meng-Ping Hsu , Jamie I. Vandenberg , Jonathan M. Kalman , Prashanthan Sanders

{"title":"Research Priorities for Atrial Fibrillation in Australia: A Statement From the Australian Cardiovascular Alliance Clinical Arrhythmia Theme","authors":"Adrian D. Elliott , Melissa E. Middeldorp , Julie R. McMullen , Diane Fatkin , Liza Thomas , Kylie Gwynne , Adam P. Hill , Catherine Shang , Meng-Ping Hsu , Jamie I. Vandenberg , Jonathan M. Kalman , Prashanthan Sanders","doi":"10.1016/j.hlc.2024.08.008","DOIUrl":null,"url":null,"abstract":"<div><div>Atrial fibrillation (AF) is highly prevalent in the Australian community, ranking amongst the highest globally. The consequences of AF are significant. Stroke, dementia and heart failure risk are increased substantially, hospitalisations are amongst the highest for all cardiovascular causes, and Australians living with AF suffer from substantial symptoms that impact quality of life. Australian research has made a significant impact at the global level in advancing the care of patients living with AF. However, new strategies are required to reduce the growing incidence of AF and its associated healthcare demand. The Australian Cardiovascular Alliance (ACvA) has led the development of an arrhythmia clinical theme with the objective of tackling major research priorities to achieve a reduction in AF burden across Australia. In this summary, we highlight these research priorities with particular focus on the strengths of Australian research and the strategies needed to move forward in reducing incident AF and improving outcomes for those who live with this chronic condition.</div></div>","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":"33 11","pages":"Pages 1523-1532"},"PeriodicalIF":2.2000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart, Lung and Circulation","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1443950624018006","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Atrial fibrillation (AF) is highly prevalent in the Australian community, ranking amongst the highest globally. The consequences of AF are significant. Stroke, dementia and heart failure risk are increased substantially, hospitalisations are amongst the highest for all cardiovascular causes, and Australians living with AF suffer from substantial symptoms that impact quality of life. Australian research has made a significant impact at the global level in advancing the care of patients living with AF. However, new strategies are required to reduce the growing incidence of AF and its associated healthcare demand. The Australian Cardiovascular Alliance (ACvA) has led the development of an arrhythmia clinical theme with the objective of tackling major research priorities to achieve a reduction in AF burden across Australia. In this summary, we highlight these research priorities with particular focus on the strengths of Australian research and the strategies needed to move forward in reducing incident AF and improving outcomes for those who live with this chronic condition.

查看原文本刊更多论文

澳大利亚心房颤动的研究重点：澳大利亚心血管联盟临床心律失常主题声明。

心房颤动（房颤）在澳大利亚社区的发病率很高，位居全球前列。心房颤动的后果非常严重。中风、痴呆症和心力衰竭的风险大大增加，住院率在所有心血管疾病中名列前茅，患有心房颤动的澳大利亚人会出现影响生活质量的严重症状。澳大利亚的研究在全球范围内对心房颤动患者的治疗产生了重大影响。然而，要降低日益增长的心房颤动发病率及其相关的医疗保健需求，还需要制定新的战略。澳大利亚心血管联盟（ACvA）牵头制定了一个心律失常临床主题，旨在解决主要的研究重点问题，以减轻澳大利亚全国的心房颤动负担。在本摘要中，我们将重点介绍这些研究重点，尤其是澳大利亚的研究优势，以及在减少心房颤动发病率和改善心房颤动这一慢性疾病患者的治疗效果方面所需的策略。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Heart, Lung and Circulation CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

4.50

自引率

3.80%

发文量

912

审稿时长

11.9 weeks

期刊介绍： Heart, Lung and Circulation publishes articles integrating clinical and research activities in the fields of basic cardiovascular science, clinical cardiology and cardiac surgery, with a focus on emerging issues in cardiovascular disease. The journal promotes multidisciplinary dialogue between cardiologists, cardiothoracic surgeons, cardio-pulmonary physicians and cardiovascular scientists.